| Identification | Back Directory | [Name]
ISX-3 | [CAS]
912789-08-3 | [Synonyms]
ISX-3
N-(3-(1H-Imidazol-1-yl)propyl)-5-(3-chlorophenyl)isoxazole-3-carboxamide
3-Isoxazolecarboxamide, 5-(3-chlorophenyl)-N-[3-(1H-imidazol-1-yl)propyl]- | [Molecular Formula]
C16H15ClN4O2 | [MOL File]
912789-08-3.mol | [Molecular Weight]
330.77 |
| Chemical Properties | Back Directory | [Boiling point ]
632.4±55.0 °C(Predicted) | [density ]
1.36±0.1 g/cm3(Predicted) | [form ]
Solid | [pka]
10.58±0.46(Predicted) | [color ]
Off-white to light yellow |
| Hazard Information | Back Directory | [Uses]
ISX-3 is a potent anti-adipogenic and pro-osteogenic agent. ISX-3 increases the expression of PPARγ. ISX-3 has the potential for the research of osteopenia and osteoporosis[1]. | [References]
[1] Nawa K, et al. Discovering small molecules that inhibit adipogenesis and promote osteoblastogenesis: unique screening and Oncostatin M-like activity. Differentiation. 2013 Jul-Sep;86(1-2):65-74. DOI:10.1016/j.diff.2013.07.005 |
|
| Company Name: |
Bide Pharmatech Ltd.
|
| Telephone: |
400-1647117 13681763483 |
| Website: |
https://www.bidepharm.com/ |
|